Research
Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy
-
* Corresponding author: Duncan Wyncoll duncan.wyncoll@gstt.nhs.uk
Critical Care 2008, 12:R163 doi:10.1186/cc7163
See related commentary by de Pont and Schultz, http://ccforum.com/content/13/1/113
No comments have yet been made on this article.